Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox – An animal model of smallpox
- 18 February 2012
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 94 (1) , 44-53
- https://doi.org/10.1016/j.antiviral.2012.02.005
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Saliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in NewbornsNew England Journal of Medicine, 2011
- Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: Pathogenesis, prophylaxis, and antiviral therapyVirology, 2011
- Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of CongoProceedings of the National Academy of Sciences, 2010
- The hairless mouse in skin researchPublished by Elsevier ,2010
- Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE® against aerosolized rabbitpox virus in a rabbit modelVaccine, 2009
- Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samplesNucleic Acids Research, 2009
- Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virusVirology, 2009
- Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapiesVirology, 2008
- Synergistic Efficacy of the Combination of ST-246 with CMX001 against OrthopoxvirusesAntimicrobial Agents and Chemotherapy, 2007
- Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in MiceAntimicrobial Agents and Chemotherapy, 2007